75% of all Alzheimer’s diagnosis are done today only after severe damage to the patient's brain has already happened. Earlier diagnosis could help to dramatically increase the quality years before the actual onset of the disease.

Based on 12 years of R&D and clinical trials with more than 2500 patients, we have developed complex everyday activities providing neuromotor biomarkers that can diagnose Alzheimer’s disease 5 years prior to onset with 94% accuracy using smartphones and augmented reality.